Laura
Leyva Fernández
Publikationen, an denen er mitarbeitet Laura Leyva Fernández (13)
2022
-
Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosis
Human Molecular Genetics, Vol. 31, Núm. 13, pp. 2155-2163
2020
-
A new risk variant for multiple sclerosis at 11q23.3 locus is associated with expansion of CXCR5+ circulating regulatory T cells
Journal of Clinical Medicine, Vol. 9, Núm. 3
2019
2016
-
Analysis of plasminogen genetic variants in multiple sclerosis patients
G3: Genes, Genomes, Genetics, Vol. 6, Núm. 7, pp. 2073-2079
2015
-
A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis
Human Molecular Genetics, Vol. 24, Núm. 19, pp. 5619-5627
-
Genome-wide significant association with seven novel multiple sclerosis risk loci
Journal of Medical Genetics, Vol. 52, Núm. 12, pp. 848-855
-
Pharmacogenomic study in patients with multiple sclerosis Responders and nonresponders to IFN-β
Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e154
2014
2013
-
Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis
Journal of Medical Genetics, Vol. 50, Núm. 1, pp. 25-33
2012
-
ANKRD55 and DHCR7 are novel multiple sclerosis risk loci
Genes and Immunity, Vol. 13, Núm. 3, pp. 253-257
2011
-
IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis
Journal of Neuroimmunology, Vol. 239, Núm. 1-2, pp. 101-104
-
Replication of top markers of a genome-wide association study in multiple sclerosis in Spain
Genes and Immunity, Vol. 12, Núm. 2, pp. 110-115
2010
-
The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis
Genes and Immunity, Vol. 11, Núm. 5, pp. 439-445